Fortress Biotech
FBIO
#9365
Rank
C$60.5 M
Marketcap
$2.19
Share price
0.00%
Change (1 day)
-42.96%
Change (1 year)

Operating Margin for Fortress Biotech (FBIO)

Operating Margin as of November 2024 (TTM): -129.54%

According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is -129.54%. At the end of 2022 the company had an Operating Margin of -281.83%.

Operating Margin history for Fortress Biotech from 2016 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-281.83%17.96%
2021-238.92%5.93%
2020-225.55%-18.73%
2019-277.54%-42.96%
2018-486.57%-13.95%
2017-565.46%30.72%
2016-432.58%-93.07%
2015-6,243.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-14,844.40% 11,359.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-13.71%-89.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-52.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.88%-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.